Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARBITER 6 - HALTS
NCT00397657Phase 4Terminated
- Sponsor
- Walter Reed Army Medical Center
- Start
- Nov 2006
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of niacin, ezetimibe in atherosclerosis, dyslipidemia, sponsored by Walter Reed Army Medical Center. Started Nov 2006; status: terminated.
02
Drugs
niacinezetimibe
03
Conditions
atherosclerosisdyslipidemia
Beyond the preview
Go deeper on NCT00397657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397657.